December 19, 2017 / 11:11 AM / 9 months ago

BRIEF-Amarin Says It Is On Track To Report Top-Line Results From REDUCE-IT Cardiovascular Outcomes Study

Dec 19 (Reuters) - Amarin Corporation Plc:

* AMARIN ANNOUNCES REDUCE-IT CARDIOVASCULAR OUTCOMES STUDY FINAL PATIENT VISITS TO COMMENCE IN MARCH 2018

* AMARIN CORPORATION PLC - CONFIRMED IT IS ON TRACK TO REPORT TOP-LINE RESULTS FROM REDUCE-IT CARDIOVASCULAR OUTCOMES STUDY BEFORE END OF Q3 2018

* AMARIN - ‍MAINTAINS GUIDANCE THAT ONSET OF TARGETED 1,612TH PRIMARY MACE IN STUDY IS PROJECTED TO OCCUR BEFORE END OF Q1 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below